A Study of Human Multi-Sensory Integration

Status Suspended

Clinical Trial Summary

The primary aim of this study is to determine whether spatiotemporal characteristics of multisensory evoked potentials can be used as a marker of consciousness (awareness) under anesthesia. The secondary aim is to characterize changes in the characteristics of evoked potentials under anesthesia in both single sensory modality (visual, auditory) and across sensory modalities.

Clinical Trial Description

This is a prospective, dual parallel arm human subject study aimed at determining the relationship between level of sedation (consciousness) and features of multi and uni-sensory evoked potentials with the ultimate goal of developing novel means of detecting consciousness under anesthesia with potential for application to other clinical settings such as brain injury. For this purpose, the investigators have chosen two anesthetics with fundamentally distinct mechanisms of action: propofol and ketamine. The study will involve healthy compensated volunteers. On the day of the study, an EEG cap will be applied to the participant for monitoring brain activity and an intravenous line will be placed for drug administration. Blood pressure, ECG, pulse oxymetry, and end-tidal carbon dioxide (from nasal cannula) will be monitored. Supplemental oxygen will be administered using a nasal cannula. Subjects will then perform the behavioral tasks in the awake state for approximately 1 hour. After this phase is complete, participants will receive either propofol or ketamine (chosen permuted block randomization) using a clinician bolus/infusion strategy titrated to Richmond Agitation-Sedation Scale score of -1 (see above). Once the desired sedation level is achieved, subjects will once again complete the behavioral tasks. After the completion of this phase (approximately 1 hour) the anesthetic dose will be increased to attain Richmond Agitation-Sedation Scale -3 to -4. At this level of sedation subjects will not be able to do the behavioral task and only the evoked potentials will be recorded. Upon completion of this phase (approximately 1 hour), sedation level will be decreased to return the subject to a Richmond Agitation-Sedation Scale of -1 and once again the tasks will be repeated. Finally, the anesthetic infusion will be stopped. Once the Richmond Agitation-Sedation Scale score of 0 is attained, participants will once again perform the behavioral task (approximately 1 hour). This will conclude the experimental phase of the trial. Subjects will be monitored until clinically established discharge criteria are met. This includes adequate respiration, blood pressure, oxygen saturation and activity level. No formal follow-up is required; however, subjects will be called 24 hours after study completion. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03498391
Study type	Interventional
Source	University of Pennsylvania
Contact
Status	Suspended
Phase	Phase 2
Start date	July 30, 2018
Completion date	May 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05346588` - THRIVE Feasibility Trial	Phase 3
Recruiting	`NCT05991453` - Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial	N/A
Completed	`NCT05656703` - Anesthesia Depth Increases Delirium Incidence	N/A
Recruiting	`NCT03773588` - Entropy and Surgical Pleth Index Guided Closed Loop Target Controlled Infusion Total Intravenous Anesthesia With Propofol	N/A
Active, not recruiting	`NCT06337877` - Assessment of Sedation Depth in ARDS Patients Undergoing Therapeutic Paralysis
Completed	`NCT03438734` - Comparison of Low Versus Normal Flow Anesthesia on Cerebral Oxygenation and Bispectral Index in Morbidly Obese Patients	N/A
Completed	`NCT06316622` - Examination of The Relationshıp Between Body Mass Index And The Skin-Epidural Space Distance	N/A
Recruiting	`NCT06323616` - The Effect of Anesthesia Depth Monitoring on Emergence Delirium in Pediatrics	N/A
Recruiting	`NCT03476213` - Manual Versus Targer-controll Infusion in Reduction of Awareness and Dreaming	N/A
Recruiting	`NCT04009018` - Adaptation of Perioperative Satisfaction Scale in Regional Anesthesia and Investigation of Its Psychometric Properties	N/A
Completed	`NCT03521414` - Glasgow Coma Scales and General Anesthesia	N/A
Completed	`NCT03134651` - Preoperative Anxiety at Oocyte Retrieval	N/A
Active, not recruiting	`NCT04826146` - Pediatric Validation of CONOX Monitor During Surgery
Recruiting	`NCT04788732` - Heart Rate Variability to Quantify General Anesthesia Depth
Recruiting	`NCT05193747` - The Depth of Paediatric Anaesthesia: Observational Trial
Completed	`NCT03807297` - TIVA vs Inhalational Mode of Anaesthesia	Phase 2
Completed	`NCT04813952` - The Effect of Minimal Flow Sevoflurane Anesthesia	N/A
Completed	`NCT03503357` - ConsCIOUS2 Study of the Isolated Forearm Technique Commands	N/A
Not yet recruiting	`NCT05254704` - Validation of the French Version of the TEX-Q Questionnaire.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

A Study of Human Multi-Sensory Integration — MSI

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms